Table 2. Base case overall survival results by analysis year.
The population expected survival life years results assume 93,500 patients are diagnosed with metastatic non‐small cell lung cancer in every analysis year to enhance comparability.
The population expected survival life years results assume 93,500 patients are diagnosed with metastatic non‐small cell lung cancer in every analysis year to enhance comparability.